The Fierce Biotech Summit is a two-day conference covering drug development from the earliest stage of research to FDA approval. The conference will spotlight the many players involved in getting a drug from the lab to the pharmacy and how companies can improve their partnership and pipeline strategies along the way. WilmerHale is a proud sponsor of this conference.
Partner Sarah Hogan will moderate a panel discussion entitled, “Evaluate Innovative Deal Structures and How to Find the Right Partner.” The panel will cover deal making within the biotech industry and what to look for when evaluating potential partners from both the big pharma and biotechnology perspectives. The panel will hear from several experienced deal makers who can speak to the motivations, decision making process and outcomes while finding the right partner.